Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

锦塔 - NMPA Drug Approval Details

Approvals/NMPA/fufang danshen tablet

Approved

中药

fufang danshen tablet

锦州汉宝药业有限公司;锦州本天药业有限公司🇨🇳 National Medical Products Administration

Approval Date: Jun 15, 2020
Approval ID: 7LeaeEPi5pF
Company: 锦州汉宝药业有限公司;锦州本天药业有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeEPi5pF
Approval Number: 国药准字Z21020084
Generic Name: 复方丹参片
Generic Name En: fufang danshen tablet
Brand Name: 锦塔
Drug Type: 中药
Dosage Form: 片剂
Strength: 每片重0.32g(相当于饮片0.6g)
Reg Date: 2020-06-15
Company Name: 锦州汉宝药业有限公司;锦州本天药业有限公司
Production Company Name: 锦州汉宝药业有限公司;锦州本天药业有限公司
Production Company Address: 锦州市高新区曙光街1号；辽宁省锦州滨海新区娘娘宫龙栖湾大道三段8号

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 15, 2020

Approval ID

7LeaeEPi5pF

Type

中药

Back to NMPA Approvals